These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15070944)

  • 1. Leptin and the proinflammatory state associated with human obesity.
    Hukshorn CJ; Lindeman JH; Toet KH; Saris WH; Eilers PH; Westerterp-Plantenga MS; Kooistra T
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1773-8. PubMed ID: 15070944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pegylated human recombinant leptin (PEG-OB) on neuroendocrine adaptations to semi-starvation in overweight men.
    Hukshorn CJ; Menheere PP; Westerterp-Plantenga MS; Saris WH
    Eur J Endocrinol; 2003 Jun; 148(6):649-55. PubMed ID: 12773137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dietary restraint during and following pegylated recombinant leptin (PEG-OB) treatment of overweight men.
    Lejeune MP; Hukshorn CJ; Saris WH; Westerterp-Plantenga MS
    Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1494-9. PubMed ID: 14634680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant methionyl human leptin administration to achieve high physiologic or pharmacologic leptin levels does not alter circulating inflammatory marker levels in humans with leptin sufficiency or excess.
    Chan JL; Bullen J; Stoyneva V; Depaoli AM; Addy C; Mantzoros CS
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1618-24. PubMed ID: 15613407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray profiling of human white adipose tissue after exogenous leptin injection.
    Taleb S; Van Haaften R; Henegar C; Hukshorn C; Cancello R; Pelloux V; Hanczar B; Viguerie N; Langin D; Evelo C; Zucker J; Clément K; Saris WH
    Eur J Clin Invest; 2006 Mar; 36(3):153-63. PubMed ID: 16506959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegylated human recombinant leptin (PEG-OB) causes additional weight loss in severely energy-restricted, overweight men.
    Hukshorn CJ; Westerterp-Plantenga MS; Saris WH
    Am J Clin Nutr; 2003 Apr; 77(4):771-6. PubMed ID: 12663271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term very low-calorie diet in obese females improves the haemostatic balance through the reduction of leptin levels, PAI-1 concentrations and a diminished release of platelet and leukocyte-derived microparticles.
    Morel O; Luca F; Grunebaum L; Jesel L; Meyer N; Desprez D; Robert S; Dignat-George F; Toti F; Simon C; Goichot B
    Int J Obes (Lond); 2011 Dec; 35(12):1479-86. PubMed ID: 21386797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men.
    Hukshorn CJ; Saris WH; Westerterp-Plantenga MS; Farid AR; Smith FJ; Campfield LA
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4003-9. PubMed ID: 11095423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of very low calorie diet induced body weight loss with or without human pegylated recombinant leptin treatment on changes in ghrelin and adiponectin concentrations.
    Lejeune MP; Hukshorn CJ; Saris WH; Westerterp-Plantenga MS
    Physiol Behav; 2007 Jun; 91(2-3):274-80. PubMed ID: 17434547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nutrigenomic inflammation-related PBMC-based approach to predict the weight-loss regain in obese subjects.
    Goyenechea E; Parra D; Crujeiras AB; Abete I; Martínez JA
    Ann Nutr Metab; 2009; 54(1):43-51. PubMed ID: 19246894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pegylated recombinant human leptin (PEG-OB) on weight loss and inflammatory status in obese subjects.
    Hukshorn CJ; van Dielen FM; Buurman WA; Westerterp-Plantenga MS; Campfield LA; Saris WH
    Int J Obes Relat Metab Disord; 2002 Apr; 26(4):504-9. PubMed ID: 12075577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild weight loss reduces inflammatory cytokines, leukocyte count, and oxidative stress in overweight and moderately obese participants treated for 3 years with dietary modification.
    Chae JS; Paik JK; Kang R; Kim M; Choi Y; Lee SH; Lee JH
    Nutr Res; 2013 Mar; 33(3):195-203. PubMed ID: 23507225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protein type within a hypocaloric diet affects obesity-related inflammation: the RESMENA project.
    Lopez-Legarrea P; de la Iglesia R; Abete I; Navas-Carretero S; Martinez JA; Zulet MA
    Nutrition; 2014 Apr; 30(4):424-9. PubMed ID: 24607301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of weight loss from a high-calcium energy-reduced diet on biomarkers of inflammatory stress, fibrinolysis, and endothelial function in obese subjects.
    Torres MR; Sanjuliani AF
    Nutrition; 2013 Jan; 29(1):143-51. PubMed ID: 23010419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome.
    Mertens I; Verrijken A; Michiels JJ; Van der Planken M; Ruige JB; Van Gaal LF
    Int J Obes (Lond); 2006 Aug; 30(8):1308-14. PubMed ID: 16389265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery.
    van Dielen FM; Buurman WA; Hadfoune M; Nijhuis J; Greve JW
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4062-8. PubMed ID: 15292349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and body fat classification in the metabolic syndrome: impact on cardiometabolic risk metabotype.
    Phillips CM; Tierney AC; Perez-Martinez P; Defoort C; Blaak EE; Gjelstad IM; Lopez-Miranda J; Kiec-Klimczak M; Malczewska-Malec M; Drevon CA; Hall W; Lovegrove JA; Karlstrom B; Risérus U; Roche HM
    Obesity (Silver Spring); 2013 Jan; 21(1):E154-61. PubMed ID: 23505198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of weight loss on high-molecular weight adiponectin in obese children.
    Martos-Moreno GÁ; Barrios V; Martínez G; Hawkins F; Argente J
    Obesity (Silver Spring); 2010 Dec; 18(12):2288-94. PubMed ID: 20339359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance.
    Caballero AE; Bousquet-Santos K; Robles-Osorio L; Montagnani V; Soodini G; Porramatikul S; Hamdy O; Nobrega AC; Horton ES
    Diabetes Care; 2008 Mar; 31(3):576-82. PubMed ID: 18083792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
    De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
    J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.